Methods for treating high somatic cell counts

Details Methods for treating high somatic cell counts Methods for treating high somatic cell counts

2006-12-12

2006-12-12

Minnifield, N. M. (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S244100, C424S234100, C424S203100, C424S241100, C424S257100, C424S258100, C424S823000, C514S002600, C514S012200

Reexamination Certificate

active

07147857

ABSTRACT:
The present invention provides methods for treating an animal having a high somatic cell count. The methods include administering compositions including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter.

REFERENCES:
patent: 4003792 (1977-01-01), Mill et al.
patent: 4167560 (1979-09-01), Wohler, Jr.
patent: 4452775 (1984-06-01), Kent
patent: 4626416 (1986-12-01), DeVoe et al.
patent: 4663161 (1987-05-01), Mannino et al.
patent: 4681761 (1987-07-01), Mietzner et al.
patent: 4748018 (1988-05-01), Stolle et al.
patent: 4871488 (1989-10-01), Mannino et al.
patent: 4981685 (1991-01-01), Healey
patent: 5141743 (1992-08-01), Schryvers
patent: 5292869 (1994-03-01), Schryvers
patent: 5439808 (1995-08-01), Blake et al.
patent: 5534256 (1996-07-01), Potter et al.
patent: 5538733 (1996-07-01), Emery et al.
patent: 5578314 (1996-11-01), Cochrum et al.
patent: 5587166 (1996-12-01), Donachie
patent: 5688682 (1997-11-01), Mulks et al.
patent: 5830479 (1998-11-01), Emery et al.
patent: 5885589 (1999-03-01), Foged et al.
patent: 5906826 (1999-05-01), Emery et al.
patent: 6027736 (2000-02-01), Emery et al.
patent: 6432412 (2002-08-01), Emery et al.
patent: 6682754 (2004-01-01), Emery et al.
patent: 6720160 (2004-04-01), Wolde-Mariam
patent: 6984503 (2006-01-01), Wang et al.
patent: 2002/0034530 (2002-03-01), Emery et al.
patent: 2003/0036639 (2003-02-01), Emery et al.
patent: 2003/0064073 (2003-04-01), Emery et al.
patent: 2003/0206922 (2003-11-01), Emery et al.
patent: 2003/0211118 (2003-11-01), Emery et al.
patent: 2004/0197350 (2004-10-01), Emery et al.
patent: 2004/0197869 (2004-10-01), Emery et al.
patent: 2004/0265329 (2004-12-01), Emery et al.
patent: 2005/0095682 (2005-05-01), Stroub et al.
patent: 2029906 (2000-09-01), None
patent: 0 287 206 (1988-10-01), None
patent: WO 90/11349 (1990-10-01), None
patent: WO 90/12591 (1990-11-01), None
patent: WO 95/21627 (1995-08-01), None
patent: WO 01/37810 (2001-05-01), None
patent: WO 01/37810 (2001-05-01), None
patent: WO 02 053180 (2002-07-01), None
Leitner et al, Vet. Immunology and Immunopathology, 2003, 93/153-158.
Bruckmaier et al, Livestock Production Science, 2005, 98(1/2):81-87 abstract only.
Crist et al, Mastitis and Its Control, In: Cooperative Extension Service, University of Kentucky College of Agriculture, 14 pages.
Vangroenweghe et al, J. Dairy Science, 2004, 87:4132-4144.
Burvenich et al, Vet. Res., 2003, 34:521-564.
Spier et al, J. Vet. Internal Medicine, Nov.-Dec. 1991, 5/6:341-350 abstract only.
Manspeaker, “Metritis and Endometritis,” [online].Northeast IRM Manual. [retrieved on Oct. 17, 2003]. Retrieved from the Internet: <URL:http://www.inform.umn.edu/EdRes/Topic/ArgEn. . ./METRITIS—AND—ENDOMETRITIS.htm>. 4 pgs.
Matsui et al., “Specificity of protective immunity induced by porin fromSalmonella typhimurium,” Microbiologica. 1991;14:103-112.
Rae, “Injection Site Reactions,” [online]. University of Florida, Department of Animal Sciences, [retrieved on Oct. 16, 2003]. Retrieved from the Internet: <URL:http://www.animal.ufl.edu/short94/rae.htm>. 3 pgs.
Tabaraie et al., “Evaluation ofSalmonellaporins as a broad spectrum vaccine candidate,”Microbiol. Immunol. 1994;38:553-559.
Todhunter et al., “Antibodies to iron-regulated outer membrane proteins of coliform bacteria isolated from bovine intramammary infections,”Vet. Immunol. Immunopath. 1991;28:107-115.
Alberti et al., “A porin fromKlebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding,”Infect Immum., Mar. 1995;63(3):903-910.
Alurkar et al., “Immunomodulatory Properties of Porins of Some Members of the familyEnterobacteriaceae,” Infection and Immunity, Jun. 1997; 65(6):2382-2388.
Ames, “Resolution of Bacterial Proteins by Polyarcylamide Gel Electrophoresis on Slabs,”J. of Biol. Chem., 1974; 249(2):634-644.
Anwar et al.. “Antibody response to acutePseudomonas aeruginosainfection in a burn wound.”FEMS Microbiology Letters. 1985: 29:225-230.
Arp, “Response of Turkeys toEscherichia coli,” Poultry Digest, Apr. 1994; 142 and 146.
Ausubel et al., eds.,Current Protocols in Molecular Biology, John Wiley & Sons, Inc., 1998; cover pg., publication pg., and table of contents only. (12 pgs.).
Banerjee-Bhatnagar et al., “Expression ofNeisseria meningitidisIron-Regulated Outer Membrane Proteins, Including a 70-Kilodalton Transferrin Receptor, and Their Potential for Use as Vaccines,”Infect. Immunity, Sep. 1990;58(9):2875-2881.
Bolin et al., “Passive Immunization with Antibodies Against Iron-Regulated Outer Membrane Proteins Protects Turkeys fromEscherichia coliSepticemia,”Infect Immun., May 1987; 55(5):1239-1242.
Boothby et al., “Characterization of Antigens from Mycoplasmas of Animal Origin,”Am J. Vet. Res., Mar. 1983; 44:433-439.
Bouchet et al., “Immunological Variants of the Aerobactin-Cloacin DF13 Outer Membrane Protein Receptor IutA among Enteric Bacteria,”Infect. and Immun., Jul. 1994; 62(7):3017-3021.
Bragg et al., “Organization of Proteins in the Native and Reformed Outer Membrane ofEscherichia Coli,” Biochim. Biophys. Acta., 1972; 274:478-488.
Brogden et al., “Lysates of Turkey-grownPasteurella multocida: Effects of Solubilizing Agents on the Immunologic Properites of Membrane Vesticles,”Am. J. Vet. Res., 1983; 44:428-432.
Chart et al., “Antigenic and molecular Homology of the Ferric Enterobactin Receptor Protein ofEscherichia coli,” J. of Gen. Microb., 1985; 131:1503-1509.
Choi-Kim et al., “Relationship between the iron regulated outer membrane proteins and the outer membrane proteins of vivo grownPasteurella multocida,” Vet. Microbiol., 1991; 28:75-92.
Coulton et al., “Protein II Influences Ferrichrome-iron Transport inEscherichia coliK12,”J. Gen. Microbiol., 1979; 110:211-220.
Courcol et al., “Siderophore production byStaphylococcus aureusand identification of iron-regulated proteins,”Infect. Immun., May 1997; 65(5):1944-1948.
Crichton, “Microbial Iron Uptake and Intracellular Release” In:Inorganic Biochemistry of Iron Metabolism, Burgess, (ed)., 1991, Ellis Horwood Limited, Chichester, England, 59-76.
Crist et al.,Mastits and its Control, [online]. University of Kentucky, College of Agriculture. [retrieved on Jul. 15, 2002]. Retrieved from the Internet:: <URL:http://www.ca.uky.edu/agc/pubs/asc/asc140/asc140.htm>. 22 pgs.
Danve et al., “Transferrin-binding proteins isolated fromNeisseria meningitidiselicit protective and bactericidal antibodies in laboratory animals,”Vaccine, 1992; 11(12):1214-1220.
Erdei et al., “Lactoferrin Binds to Porins OmpF and OmpC inEscherichia coli,” Infec. Immun., Apr. 1994; 62(4):1236-1240.
Feng et al., “P55, an Immunogenic but Nonprotective 55-KilodaltonBorrelia burgdorferiProtein in Murine Lyme Disease,”Infect. and Immun., Jan. 1996; 64(1):363-365.
Ferguson et al., “Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide,”Science, Dec. 18, 1998; 282(5397):2215-2220.
Filip et al., “Solubilization of the Cytoplasmic Membrane ofEscherichia coliby the Ionic Detergent Sodium-Lauryl Sarcosinate,”J. Bacteriology, Sep. 1973; 115(3):717-722.
Finkelstein et al., “Role of Iron in Microbe-Host Interactions,”Reviews of Infectious Diseases, Sep.-Oct. 1983; 5(Suppl. 4):S759-S776.
Francis et al., “Immunological Priming with Synthetic Peptides of Foot-and-Mouth Disease Virus,”J. Gen. Virol., 1985; 66:2347-2354.
Furugouri, “Iron Binding Substances in the Intestinal Mucosa of Neonatal Piglets,”J. Nutr., Mar. 1977; 107(3):487-494.
Gilleland, Jr. et al., “Perspectives on the Potential for Successful Development of O

Affiliated with

Also associated with

Rating

Methods for treating high somatic cell counts does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating high somatic cell counts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating high somatic cell counts will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3672971